Clinical Trials Browser

Phase 2 × niraparib × Tumor-Agnostic × Clear all

NCT04341181 2025-07-25

ProTarget

Phase 2 Recruiting

Neoplasms

NCT04817956 2024-02-29

IMPRESS-N

Phase 2 Recruiting

Neoplasm Metastasis

NCT03308942 2023-10-16

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

Phase 2 Completed

53 enrolled 35 charts

Neoplasms